Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.12.2022 | Case report

Cariprazine/olanzapine

Insomnia and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ivanov SV, et al. Early Clinical Effects of Novel Partial D3/D2 Agonist Cariprazine in Schizophrenia Patients With Predominantly Negative Symptoms (Open-Label, Non-controlled Study). Frontiers in Psychiatry 12: 24 Jan 2022. Available from: URL: http://doi.org/10.3389/fpsyt.2021.770592 Ivanov SV, et al. Early Clinical Effects of Novel Partial D3/D2 Agonist Cariprazine in Schizophrenia Patients With Predominantly Negative Symptoms (Open-Label, Non-controlled Study). Frontiers in Psychiatry 12: 24 Jan 2022. Available from: URL: http://​doi.​org/​10.​3389/​fpsyt.​2021.​770592
Metadaten
Titel
Cariprazine/olanzapine
Insomnia and lack of efficacy: case report
Publikationsdatum
01.12.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-28926-4

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Multiple drugs

Case report

Methadone

Case report

Dexmedetomidine